Benchmark analyst Josh Sullivan maintains Ultralife (NASDAQ:ULBI) with a Buy and raises the price target from $13 to $14.
- Headlines
- Benchmark Maintains Buy on Ultralife, Raises Price Target to $14
Benchmark Maintains Buy on Ultralife, Raises Price Target to $14
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
16:22
South Korean media: The Chief of the South Korean Army General Staff has reportedly resigned over the emergency martial law controversy.
16:20
The Hebei Provincial Development and Reform Commission organized a symposium on the coordination mechanism for supporting financing for micro and small enterprises.
16:20
The National Development and Reform Commission: Support the issuance and listing of REITs projects in the winter sports economy that meet certain conditions.